Skip to content
Toggle main navigation
MPN World logo
MPN World logo
  • Home
  • Description how to move to the new MPN World.
  • What is MPN World?
  • Benefits of Joining
  • How to Join?
  • FAQs
    Log in
    Select an available language
    EN

    The latest MPN-News

    from all over the world.

     

    Picked from reliable sources by our redaction

    (Language is English)

    All
    01 ET Clinical trials
    02 PV Clinical trials
    03 MF Clinical trials
    04 Basic information about MPNs / Basisinformatie over MPN's / Información básica sobre las MPN
    05 Diagnosed with MPNs / Gediagnosticeerd met MPN's / Diagnosticados con MPN
    06 Living with MPNs / Leven met MPN's / Viviendo con MPN
    07 Women and pregnancy / Vrouwen en zwangerschap / Mujeres y embarazo
    20 Medication/ Medicatie/ Medicación
    70 Research/ Onderzoek /Investigación

    Results (20)

    Reflections after IHEM 2026

    Reflections after IHEM 2026

    From May 7th to 9th, the International Hematology Expert Meeting (IHEM®) 2026 took place in Sitges, Spain, bringing together leading international experts, hematologists, and researchers focused on myeloproliferative neoplasms (MPNs).The event, originally initiated by Prof. Heinz Gisslinger, is one of the most recognized scientific meetings in the MPN field and focuses on new research, emerging th
    May 13, 2026
    New video: USA Webinar I Talking about Essential Thrombocythemia (ET) and promising treatments in the US

    New video: USA Webinar I Talking about Essential Thrombocythemia (ET) and promising treatments in the US

    New video available from the webinar focused on Essential Thrombocythemia (ET) and the future of treatment options in the United States.Last April 24th, 2026, thanks to the knowledge of Prof. Lucia Masarova, MD, Assistant Professor in the Department of Leukemia, Division of Cancer Medicine at MD Anderson Cancer Center (USA), the global MPN community, had the opportunity to better understand how cl
    May 8, 2026
    Heading to IHEM 2026!

    Heading to IHEM 2026!

    The Global MPN Scientific Foundation will be present at IHEM® 2026 (International Hematology Expert Meeting), taking place from May 7th to 9th in Sitges, Spain.Our Founder & CEO, Peter Löffelhardt, will attend both as a patient representative and as part of GMPNSF, bringing the perspective of the global MPN community into this important scientific space.If you would like to connect with him during
    May 1, 2026
    Honoring Dr. Richard T. Silver. A life dedicated to MPN patients

    Honoring Dr. Richard T. Silver. A life dedicated to MPN patients

    At the Global MPN Scientific Foundation, we are deeply saddened to share the passing of Dr. Richard T. Silver, who died on April 17th, 2026, at the age of 97.Dr. Silver was more than a leading figure in myeloproliferative neoplasms (MPNs), he was a pioneer, a mentor, and a physician whose work has shaped the lives of countless patients around the world.A recognition that reflects a lifetime of imp
    April 22, 2026
    Cancer Patients Europe (CPE) and MPNs

    Cancer Patients Europe (CPE) and MPNs

    We are very pleased to share an important milestone for the MPN community!The Global MPN Scientific Foundation is now an official member of Cancer Patients Europe (CPE), a leading European network that brings together patient organizations to strengthen the voice of people living with cancer across Europe.This step represents an important opportunity to ensure that myeloproliferative neoplasms (MP
    March 20, 2026
    POIESIS Clinical Trial: Latest Updates with Dr. Vachhani

    POIESIS Clinical Trial: Latest Updates with Dr. Vachhani

    New research developments in myelofibrosis that may open therapeutic opportunities and provide relevant information for patients and families.Myelofibrosis is a chronic myeloproliferative neoplasm that can cause persistent symptoms such as severe fatigue, enlarged spleen, night sweats, weight loss, or difficulty maintaining a normal daily routine. In recent years, JAK inhibitors have represented a
    March 10, 2026
    Research in MPN. History, Present and Future | An Exclusive Interview with Prof. Radek Skoda and Prof. Ruben Mesa

    Research in MPN. History, Present and Future | An Exclusive Interview with Prof. Radek Skoda and Prof. Ruben Mesa

    As the final surprise of our Advent Calendar, the Global MPN Scientific Foundation is proud to share a very special holiday gift with our community: an exclusive interview with Prof. Radek Skoda and Prof. Ruben Mesa, recorded in connection with one of the most important moments of ASH 2025.This unique conversation brings together two of the most influential leaders in myeloproliferative neoplasms.
    December 24, 2025
    Exclusive: Video from ASH 2025 Highlights Webinar Now Available

    Exclusive: Video from ASH 2025 Highlights Webinar Now Available

    Yesterday, we closed the year with an excellent live webinar reviewing the key scientific highlights from #ASH2025, the world’s leading congress in hematology. VIDEO NOW AVAILABLE!This important session brought together two of the most respected voices in the MPN field:Prof. Ruben Mesa, internationally recognized MPN expert, President of Advocate Health Cancer Institute and Executive Director of W
    December 17, 2025
    Meet Peter Löffelhardt at ESMO 2025 in Berlin

    Meet Peter Löffelhardt at ESMO 2025 in Berlin

    We are pleased to announce that Peter Löffelhardt, Founder and CEO of the Global MPN Scientific Foundation, will attend the European Society for Medical Oncology (ESMO) Congress 2025, one of the world’s most influential gatherings in oncology.🗓 October 17 to 21, 2025📍 Berlin, GermanyESMO is the global platform where leading experts in cancer care come together with researchers, advocates, and th
    October 8, 2025
    Videos | Webinar: New Treatment for PV with Prof. Susanne Isfort and Silence Therapeutics

    Videos | Webinar: New Treatment for PV with Prof. Susanne Isfort and Silence Therapeutics

    Last August 28th, the Global MPN Scientific Foundation hosted a special webinar together with Silence Therapeutics, a biotech company developing precision RNA-based therapies for rare diseases such as Polycythemia Vera (PV).This session brought together:Prof. Susanne Isfort, hematologist, clinical researcher, and MPN expert from Germany.Alberto Martinez, Senior Director of Clinical Science at Sile
    September 29, 2025
    MPN Awareness Day 2025: Let’s Make Sure Our Voice Is Heard Everywhere

    MPN Awareness Day 2025: Let’s Make Sure Our Voice Is Heard Everywhere

    A time to raise our voices, build hope, and come together as a global communityEvery second Thursday of September (this year is September 11th, 2025), we mark MPN Awareness Day, a moment to make visible what often remains invisible.Myeloproliferative Neoplasms (MPNs) are rare blood cancers that affect the bone marrow and lead to the abnormal growth of blood cells. They can cause serious complicati
    September 11, 2025
    Keep track of MPN symptoms

    Keep track of MPN symptoms

    Groot Nieuws!MPN World lanceert een wereldwijd initiatief om gegevens te verzamelen over de relatie tussen symptomen, complicaties, medicatie, bijwerkingen en levensstijl.Hiermee krijg je zelf inzicht in hoe symptomen en bijwerking beinvloed worden door medicatie en lifestyle. Je kunt oo de rapportage printen en meenemen naar je consult. Daarmee kun je concreter praten over je symptomen en medicat
    July 1, 2025
    Navigating MPNs with Prof. Susanne Isfort

    Navigating MPNs with Prof. Susanne Isfort

    At the Global MPN Scientific Foundation, we are committed to providing valuable resources for individuals living with Myeloproliferative Neoplasms (MPNs). Our latest interview with Prof. Susanne Isfort, now available on MPN World, offers essential insights into managing MPNs and improving quality of life.        Prof. Isfort explains the different types of MPNs, highlighting their common symptoms
    March 6, 2025
    Understanding Abnormal Blood Counts

    Understanding Abnormal Blood Counts

    What do they mean, and how are they tested? Blood is a vital fluid that carries oxygen and nutrients to all cells in our body. It helps fight infections and heal wounds. Blood is made up of different types of cells. A complete blood count (CBC) is a standard blood test that measures the number and quality of these cells.                 A CBC can help diagnose various conditions, such as anemia, i
    March 3, 2025
    Allele Burden and MPNs Explained by Prof. Lucia Masarova

    Allele Burden and MPNs Explained by Prof. Lucia Masarova

    At the 4th MPN Spring Symposium in Barcelona, Prof. Lucia Masarova, Assistant Professor at The University of Texas MD Anderson Cancer Center, discussed the concept of allele burden and its role in managing Myeloproliferative Neoplasms (MPNs).            She explained how the percentage of cells with a specific mutation can impact disease progression, guide treatment decisions, and predict patient
    February 10, 2025
    Videos from the Webinar “What is a Combo Treatment in MPN?”

    Videos from the Webinar “What is a Combo Treatment in MPN?”

    On December 23rd, 2024, the Global MPN Scientific Foundation hosted a special webinar focused on combo treatments for MPNs. The session, moderated by Peter Loffelhardt, featured Prof. Haifa Al-Ali and specialists from Karyopharm, who discussed a new clinical trial combining Jakavi with other treatments.The webinar offered valuable insights into the potential benefits and challenges of combination
    January 13, 2025
    Prevention of Thrombotic Events in MPN: Insights from Prof. Martin Ellis

    Prevention of Thrombotic Events in MPN: Insights from Prof. Martin Ellis

    At the 4th MPN Spring Symposium, Prof. Martin Ellis and specialists discussed the prevention of thrombotic events in myeloproliferative neoplasms (MPNs), particularly in polycythemia vera (PV). They emphasized the need for a multidisciplinary approach in managing thrombotic risks, highlighting genetic monitoring (JAK2, CALR, MPL) and treatment strategies such as antithrombotic therapy, aspirin, an
    January 10, 2025
    Nutrition and Well-Being: Key Insights from Carla Not

    Nutrition and Well-Being: Key Insights from Carla Not

    Nutrition plays a crucial role in managing health, especially for individuals affected by myeloproliferative neoplasms (MPNs). In a recent presentation, Carla Not, an expert in nutrition, highlighted the significance of a balanced diet in supporting overall health and well-being for MPN patients. Her insights shed light on how proper nutrition can not only help manage symptoms but also improve ene
    November 6, 2024
    Dr. Laura Fox presents the basics of MPN

    Dr. Laura Fox presents the basics of MPN

    The 4th MPN Spring Symposium provided an invaluable platform for healthcare professionals and researchers to explore the intricacies of Myeloproliferative Neoplasms (MPNs). Among the notable presentations was Dr. Laura Fox, a respected expert in the field, who discussed the basics of MPNs, shedding light on these rare blood disorders. Her long-standing collaboration with the Global MPN Scientific
    October 7, 2024
    Informal talk with Prof. Haifa Al-Ali

    Informal talk with Prof. Haifa Al-Ali

    In this engaging series of videos, Peter Loffelhardt, President and CEO of the Global MPN Scientific Foundation, had the privilege of interviewing Prof. Haifa Al-Ali, a distinguished specialist in myeloproliferative neoplasms (MPNs) and Senior Physician at the University Clinic for Internal Medicine IV. With a clinical focus on treating patients with acute and chronic malignant myeloid diseases, i
    October 4, 2024
    Contact
    Global MPN Scientific Foundation
    Avenida Josep Tarradellas 157, 5o 2a - Barcelona, 08029 - Spain
    info@gmpnsf.org
    Links
    • Terms of Use
    • About Global MPNSF
    • Privacy Policy
    Cookies
    Reselect cookie settings
    Community engagement platform by Hivebrite.